Risk Assessment for Postoperative Delirium (RAPID)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02377115|
Recruitment Status : Completed
First Posted : March 3, 2015
Last Update Posted : April 25, 2018
|Condition or disease||Intervention/treatment||Phase|
|Postoperative Delirium||Other: Tablet computer application||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||54 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Risk Assessment for Postoperative Delirium: Derivation of a Self-Administered Tablet Computer-based Clinical Screening Tool|
|Study Start Date :||March 2015|
|Actual Primary Completion Date :||December 2015|
|Actual Study Completion Date :||April 2016|
Tablet computer application
Other: Tablet computer application
Preoperatively, all study participants (entire cohort) will perform in the self-administered tablet computer-based tool to assess the risk of developing POD.
- Incidence of POD. [ Time Frame: Day 1-5 after surgery. ]Incidence of POD, detected by the DRS-R-98.
- Severity of POD. [ Time Frame: Day 1-5 after surgery. ]Severity of POD, measured by the DRS-R-98.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02377115
|University Hospital Basel|
|Basel, Switzerland, 4031|
|Principal Investigator:||Nicolai Goettel, MD||University Hospital, Basel, Switzerland|